Oxacillin-resistant phenotypes of Staphylococcus aureus

被引:8
作者
Haberberger, RL [1 ]
Kallen, AJ [1 ]
Driscoll, TJ [1 ]
Wallace, MR [1 ]
机构
[1] Natl Naval Med Ctr, Dept Lab, Complex Testing Div, San Diego, CA 92134 USA
关键词
D O I
10.1093/labmed/29.5.302
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Infections caused by oxacillin-resistant Staphylococcus aureus are a growing problem in the United States, accounting for considerable morbidity, mortality, and expense. The increasing incidence of these infections has led to frequent empiric use of broader spectrum antibiotics to treat these more resistant pathogens, contributing to further worsening of the resistance among gram-positive organisms. Three main mechanisms of oxacillin resistance in S aureus are described: (1) classic resistance, (2) modified S aureus phenotype, and (3) hyper-beta-lactamase production. Correctly identifying the mechanism of resistance in S aureus isolates should lend to substantial changes in antibiotic use and in infection control protocols. These modifications in clinical practices could lead to cost savings, as well as a decreased potential for further antibiotic resistance.
引用
收藏
页码:302 / 305
页数:4
相关论文
共 13 条
[1]  
[Anonymous], METH DIL ANT SUSC TE
[2]   Methicillin resistance in staphylococci: Molecular and biochemical basis and clinical implications [J].
Chambers, HF .
CLINICAL MICROBIOLOGY REVIEWS, 1997, 10 (04) :781-+
[3]  
JACOBY GA, 1991, NEW ENGL J MED, V324, P601, DOI 10.1056/NEJM199102283240906
[4]  
Kallen A. J., 1997, Clinical Infectious Diseases, V25, P492
[5]   BETA-LACTAMASES IN LABORATORY AND CLINICAL RESISTANCE [J].
LIVERMORE, DM .
CLINICAL MICROBIOLOGY REVIEWS, 1995, 8 (04) :557-&
[6]   IMPLICATIONS OF ACQUIRED OXACILLIN RESISTANCE IN THE MANAGEMENT AND CONTROL OF STAPHYLOCOCCUS-AUREUS INFECTIONS [J].
MASSANARI, RM ;
PFALLER, MA ;
WAKEFIELD, DS ;
HAMMONS, GT ;
MCNUTT, LA ;
WOOLSON, RF ;
HELMS, CM .
JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (04) :702-709
[7]   THE ROLE OF BETA-LACTAMASE IN STAPHYLOCOCCAL RESISTANCE TO PENICILLINASE-RESISTANT PENICILLINS AND CEPHALOSPORINS [J].
MCDOUGAL, LK ;
THORNSBERRY, C .
JOURNAL OF CLINICAL MICROBIOLOGY, 1986, 23 (05) :832-839
[8]   Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Therapeutic realities and possibilities [J].
Michel, M ;
Gutmann, L .
LANCET, 1997, 349 (9069) :1901-1906
[9]  
Mitchell JM, 1996, NEW ZEAL MED J, V109, P411
[10]   METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS (MRSA) IN THE COMMUNITY - WHOS WATCHING [J].
ROSENBERG, J .
LANCET, 1995, 346 (8968) :132-133